Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

BACKGROUND: Biologically targeted therapies have been postulated as a viable strategy to improve outcomes for women with ovarian cancer. We assessed the safety, tolerance, pharmacokinetics, relevant circulating and image-derived biomarkers, and clinical activity of combination aflibercept and doceta...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Coleman, Robert L, Duska, Linda R, Ramirez, Pedro T, Heymach, John V, Kamat, Aparna A, Modesitt, Susan C, Schmeler, Kathleen M, Iyer, Revathy B, Garcia, Michael E, Millera, Debbie L, Jackson, Edward F, Ng, Chaan S, Kundra, Vikas, Jaffe, Robert, Sood, Anil K
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2011
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3444811/
https://ncbi.nlm.nih.gov/pubmed/21992853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70244-3
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla